Cargando…
A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes
OBJECTIVE: To describe the impact of initiating raltegravir (RAL)-containing combination antiretroviral therapy (cART) regimens on HIV viral load (VL) in pregnant women who have high or suboptimal VL suppression late in pregnancy. METHODS: HIV-infected pregnant women who started RAL-containing cART...
Autores principales: | Boucoiran, I, Tulloch, K, Pick, N, Kakkar, F, van Schalkwyk, J, Money, D, Boucher, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pulsus Group Inc
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507840/ https://www.ncbi.nlm.nih.gov/pubmed/26236356 |
Ejemplares similares
-
Relationship between raltegravir trough plasma concentration and
virologic response and the impact of therapeutic drug monitoring during
pregnancy
por: Carvalho, Sabrina, et al.
Publicado: (2022) -
Obstetrical outcome in the third trimester after hysteroscopic adhesiolysis
por: Torres-de la Roche, Luz Angela, et al.
Publicado: (2020) -
Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019) -
Non-Gynecologic Laparoscopy in Second and Third Trimester Pregnancy: Obstetric Implications
por: Geisler, John P., et al.
Publicado: (1998) -
Maternal Zika Virus Infection in the First Trimester and Fetal Stigmata in the Third Trimester
por: Singh, Divya, et al.
Publicado: (2023)